Responses

Download PDFPDF

The CLIMB (Complex Lipids In Mothers and Babies) study: protocol for a multicentre, three-group, parallel randomised controlled trial to investigate the effect of supplementation of complex lipids in pregnancy, on maternal ganglioside status and subsequent cognitive outcomes in the offspring
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    The CLIMB (Complex Lipids In Mothers and Babies) study
    • Philip N Baker, Pro-Vice-Chancellor, Head of the College of Life Sciences, Dean of Medicine University of Leicester

    Dear Sir/Madam

    We have been alerted to an error in our paper:

    The text: Our primary objectives are: i) evaluate the impact of maternal dietary CML intake on maternal and infant complex lipid status by comparing outcomes of product A with product B and a reference group and; ii) investigate the benefits of the fortified maternal milk products (containing CML) on maternal health and nutritional status, and general infant health and neurodevelopment.

    Should have read: Our primary objectives are: i) evaluate the impact of maternal dietary CML intake on maternal complex lipid status by comparing outcomes of product A with product B and a reference group and; ii) investigate the benefits of the fortified maternal milk products (containing CML) on maternal health and nutritional status. Secondary outcomes include the effects of the products on infant complex lipid status, and on general infant health and neurodevelopment.

    We would be most grateful if an erratum/correction could be published on line

    Philip N Baker, on behalf of the CLIMB team

    Conflict of Interest:
    None declared.